-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Short Interest in BioPlus Acquisition Corp. (NASDAQ:BIOS) Decreases By 53.3%
Short Interest in BioPlus Acquisition Corp. (NASDAQ:BIOS) Decreases By 53.3%
BioPlus Acquisition Corp. (NASDAQ:BIOS – Get Rating) was the target of a large drop in short interest in December. As of December 15th, there was short interest totalling 1,400 shares, a drop of 53.3% from the November 30th total of 3,000 shares. Based on an average daily volume of 41,500 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the shares of the stock are short sold.
Hedge Funds Weigh In On BioPlus Acquisition
A number of large investors have recently made changes to their positions in the stock. Millennium Management LLC increased its holdings in shares of BioPlus Acquisition by 13.6% in the 2nd quarter. Millennium Management LLC now owns 1,124,521 shares of the company's stock valued at $11,178,000 after purchasing an additional 135,001 shares in the last quarter. Polar Asset Management Partners Inc. grew its stake in BioPlus Acquisition by 31.0% in the 3rd quarter. Polar Asset Management Partners Inc. now owns 1,056,666 shares of the company's stock valued at $10,619,000 after acquiring an additional 250,000 shares during the last quarter. Cantor Fitzgerald L. P. grew its stake in BioPlus Acquisition by 6.3% in the 3rd quarter. Cantor Fitzgerald L. P. now owns 850,000 shares of the company's stock valued at $8,542,000 after acquiring an additional 50,000 shares during the last quarter. Goldman Sachs Group Inc. acquired a new stake in BioPlus Acquisition in the 1st quarter valued at about $8,152,000. Finally, Starboard Value LP acquired a new stake in BioPlus Acquisition in the 1st quarter valued at about $6,098,000. Hedge funds and other institutional investors own 72.81% of the company's stock.
Get BioPlus Acquisition alerts:BioPlus Acquisition Stock Performance
Shares of BIOS traded up $0.04 during trading hours on Friday, reaching $10.25. The company had a trading volume of 10 shares, compared to its average volume of 14,359. The firm has a 50 day simple moving average of $10.17 and a 200-day simple moving average of $10.06. BioPlus Acquisition has a 12-month low of $9.78 and a 12-month high of $10.23.
BioPlus Acquisition Company Profile
(Get Rating)BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.
Further Reading
- Get a free copy of the StockNews.com research report on BioPlus Acquisition (BIOS)
- The Dogs Of Tech: It's Time For A Bite Of These Stocks
- Does This Acquisition Make Microsoft a Bear Market Buy?
- Is Kintara Therapeutics A Hidden Gem?
- Should You Warm up to Generac Stock for the Winter?
- 3 High-Yield Dividend Stocks to Hold for the Long Haul
Receive News & Ratings for BioPlus Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPlus Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
生物科技收购公司(纳斯达克代码:Bios-Get Rating)是空头股数12月份股价大幅下跌的目标。截至12月15日,空头股数共有1,400股,较11月30日的3,000股下降了53.3%。以日均成交量41,500股计算,目前天数与回补比率为0.0天。目前,该股有0.0%的股份被卖空。
对冲基金参与收购BioPlus
一些大型投资者最近改变了他们在该股的头寸。Millennium Management LLC在第二季度增持了BioPlus收购的股票13.6%。Millennium Management LLC在上个季度额外购买了135,001股后,现在拥有1,124,521股该公司的股票,价值11,178,000美元。Polal Asset Management Partners Inc.在第三季度将其在BioPlus收购中的持股增加了31.0%。Polal Asset Management Partners Inc.在上个季度增持了250,000股后,现在持有1,056,666股该公司股票,价值10,619,000美元。Cantor Fitzgerald L.P.在第三季度将其在BioPlus收购中的持股增加了6.3%。康托·菲茨杰拉德在上个季度增持了5万股后,现在持有该公司85万股股票,价值8,542,000美元。高盛股份有限公司在第一季度收购了BioPlus收购公司的新股份,价值约8,152,000美元。最后,Starboard Value LP在第一季度收购了BioPlus收购的新股份,价值约6,098,000美元。对冲基金和其他机构投资者持有该公司72.81%的股票。
到达收购BioPlus警报:BioPlus收购股票表现
在周五的交易时间里,基本输入输出系统的股价上涨了0.04美元,达到10.25美元。该公司的交易量为10股,而其平均成交量为14,359股。该公司的50日简单移动均线切入位在10.17美元,200日简单移动均线切入位在10.06美元。BioPlus的收购价为9.78美元,为12个月低点,12个月高位为10.23美元。
BioPlus收购公司简介
(获取评级)BioPlus收购公司没有重要的业务。拟与生命科学行业的一项或多项业务进行合并、股份交换、资产收购、股份购买、重组或其他类似业务合并。该公司成立于2021年,总部设在纽约。
进一步阅读
- 免费获取StockNews.com关于BioPlus收购(BIOS)的研究报告
- 科技狗:是时候咬一口这些股票了
- 这笔收购会让微软成为熊市买入者吗?
- 金塔拉治疗公司是一颗隐藏的宝石吗?
- 你应该热身到Generac股票过冬吗?
- 长期持有的3只高收益股利股票
每日收到BioPlus收购的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对BioPlus收购和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧